| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGEF19 NET1 RASGRF2 MON1A ARHGAP11A NPRL2 RAB3GAP1 SRGAP3 SRGAP1 HERC2 MCF2L ARHGAP11B TNS3 | 1.05e-05 | 507 | 119 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGEF19 NET1 RASGRF2 MON1A ARHGAP11A NPRL2 RAB3GAP1 SRGAP3 SRGAP1 HERC2 MCF2L ARHGAP11B TNS3 | 1.05e-05 | 507 | 119 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGEF19 NLRP7 NET1 RASGRF2 ANXA4 MON1A ARHGAP11A SOCS7 NPRL2 RAB3GAP1 PPP2R5A PPP2R5C PPP2R5D SRGAP3 SRGAP1 PRKAG1 PRKCD C5 HERC2 MCF2L ARHGAP11B TNS3 | 2.98e-05 | 1418 | 119 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | glucosamine-6-phosphate deaminase activity | 3.52e-05 | 2 | 119 | 2 | GO:0004342 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.32e-04 | 17 | 119 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 2.18e-04 | 20 | 119 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 2.48e-04 | 94 | 119 | 5 | GO:0050660 | |
| GeneOntologyMolecularFunction | helicase activity | 3.71e-04 | 158 | 119 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 4.73e-04 | 231 | 119 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 9.51e-04 | 189 | 119 | 6 | GO:0004721 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.38e-03 | 37 | 119 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.43e-03 | 279 | 119 | 7 | GO:0005096 | |
| GeneOntologyBiologicalProcess | glucosamine catabolic process | 3.19e-05 | 2 | 117 | 2 | GO:0006043 | |
| GeneOntologyBiologicalProcess | UDP-N-acetylglucosamine metabolic process | 6.19e-05 | 14 | 117 | 3 | GO:0006047 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 7.69e-05 | 77 | 117 | 5 | GO:0035567 | |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 9.05e-05 | 128 | 117 | 6 | GO:0035303 | |
| GeneOntologyBiologicalProcess | N-acetylglucosamine catabolic process | 9.54e-05 | 3 | 117 | 2 | GO:0006046 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 9.54e-05 | 3 | 117 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.07e-04 | 256 | 117 | 8 | GO:0006470 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGEF19 NET1 RASGRF2 ADGRG1 ARHGAP11A SRGAP3 MCF2L ARHGAP11B TNS3 | 1.20e-04 | 333 | 117 | 9 | GO:0051056 |
| GeneOntologyBiologicalProcess | dephosphorylation | 1.63e-04 | 347 | 117 | 9 | GO:0016311 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 1.38e-04 | 18 | 119 | 3 | GO:0000159 | |
| HumanPheno | Clitoral hypoplasia | 9.85e-06 | 34 | 45 | 5 | HP:0000060 | |
| HumanPheno | Aplasia/Hypoplasia of the clitoris | 9.85e-06 | 34 | 45 | 5 | HP:0040255 | |
| HumanPheno | Hypoplastic labia minora | 1.14e-05 | 35 | 45 | 5 | HP:0000064 | |
| HumanPheno | Abnormal labia minora morphology | 2.53e-05 | 41 | 45 | 5 | HP:0012880 | |
| Domain | Dishevelled | 9.54e-07 | 4 | 117 | 3 | PF02377 | |
| Domain | Dishevelled_fam | 9.54e-07 | 4 | 117 | 3 | IPR008339 | |
| Domain | Dishevelled_protein_dom | 9.54e-07 | 4 | 117 | 3 | IPR003351 | |
| Domain | PP2A_B56 | 2.37e-06 | 5 | 117 | 3 | IPR002554 | |
| Domain | B56 | 2.37e-06 | 5 | 117 | 3 | PF01603 | |
| Domain | DIX | 8.23e-06 | 7 | 117 | 3 | PF00778 | |
| Domain | DIX | 8.23e-06 | 7 | 117 | 3 | IPR001158 | |
| Domain | DIX | 8.23e-06 | 7 | 117 | 3 | PS50841 | |
| Domain | DAX | 8.23e-06 | 7 | 117 | 3 | SM00021 | |
| Domain | Glucosamine6P_isomerase_CS | 3.89e-05 | 2 | 117 | 2 | IPR018321 | |
| Domain | Glucosamine6P_isomerase | 3.89e-05 | 2 | 117 | 2 | IPR004547 | |
| Domain | GLC_GALNAC_ISOMERASE | 3.89e-05 | 2 | 117 | 2 | PS01161 | |
| Domain | DVL-1 | 3.89e-05 | 2 | 117 | 2 | IPR008340 | |
| Domain | BRINP | 1.16e-04 | 3 | 117 | 2 | IPR033237 | |
| Domain | Dishevelled_C-dom | 1.16e-04 | 3 | 117 | 2 | IPR024580 | |
| Domain | VPS13 | 1.16e-04 | 3 | 117 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.16e-04 | 3 | 117 | 2 | PF16910 | |
| Domain | VPS13 | 1.16e-04 | 3 | 117 | 2 | PF16908 | |
| Domain | Dsh_C | 1.16e-04 | 3 | 117 | 2 | PF12316 | |
| Domain | VPS13_N2 | 1.16e-04 | 3 | 117 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.16e-04 | 3 | 117 | 2 | IPR031642 | |
| Domain | SHR-BD | 2.32e-04 | 4 | 117 | 2 | IPR009543 | |
| Domain | Dsh/Dvl-rel | 2.32e-04 | 4 | 117 | 2 | IPR015506 | |
| Domain | VPS13_C | 2.32e-04 | 4 | 117 | 2 | PF16909 | |
| Domain | Glc/Gal-6P_isomerase | 2.32e-04 | 4 | 117 | 2 | IPR006148 | |
| Domain | VPS13_C | 2.32e-04 | 4 | 117 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.32e-04 | 4 | 117 | 2 | PF06650 | |
| Domain | Glucosamine_iso | 2.32e-04 | 4 | 117 | 2 | PF01182 | |
| Domain | PDZ | 2.62e-04 | 141 | 117 | 6 | PF00595 | |
| Domain | DEP | 3.38e-04 | 22 | 117 | 3 | PF00610 | |
| Domain | DEP | 3.38e-04 | 22 | 117 | 3 | PS50186 | |
| Domain | DEP | 3.38e-04 | 22 | 117 | 3 | SM00049 | |
| Domain | PDZ | 3.40e-04 | 148 | 117 | 6 | SM00228 | |
| Domain | PDZ | 3.78e-04 | 151 | 117 | 6 | PS50106 | |
| Domain | DEP_dom | 3.87e-04 | 23 | 117 | 3 | IPR000591 | |
| Domain | Spectrin | 3.87e-04 | 23 | 117 | 3 | PF00435 | |
| Domain | PDZ | 3.92e-04 | 152 | 117 | 6 | IPR001478 | |
| Domain | SH2 | 4.34e-04 | 101 | 117 | 5 | PF00017 | |
| Domain | Helicase_C | 5.66e-04 | 107 | 117 | 5 | PF00271 | |
| Domain | HELICc | 5.66e-04 | 107 | 117 | 5 | SM00490 | |
| Domain | Helicase_C | 5.90e-04 | 108 | 117 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 6.16e-04 | 109 | 117 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.16e-04 | 109 | 117 | 5 | PS51192 | |
| Domain | DEXDc | 6.16e-04 | 109 | 117 | 5 | SM00487 | |
| Domain | RhoGAP | 6.17e-04 | 62 | 117 | 4 | SM00324 | |
| Domain | Helicase_ATP-bd | 6.42e-04 | 110 | 117 | 5 | IPR014001 | |
| Domain | SH2 | 6.42e-04 | 110 | 117 | 5 | SM00252 | |
| Domain | RhoGAP | 6.55e-04 | 63 | 117 | 4 | PF00620 | |
| Domain | DH_1 | 6.55e-04 | 63 | 117 | 4 | PS00741 | |
| Domain | SH2 | 6.69e-04 | 111 | 117 | 5 | PS50001 | |
| Domain | RhoGAP_dom | 6.96e-04 | 64 | 117 | 4 | IPR000198 | |
| Domain | RHOGAP | 6.96e-04 | 64 | 117 | 4 | PS50238 | |
| Domain | - | 6.96e-04 | 64 | 117 | 4 | 1.10.555.10 | |
| Domain | SH2 | 6.97e-04 | 112 | 117 | 5 | IPR000980 | |
| Domain | - | 6.97e-04 | 112 | 117 | 5 | 3.30.505.10 | |
| Domain | FYVE | 7.77e-04 | 29 | 117 | 3 | PF01363 | |
| Domain | FYVE | 7.77e-04 | 29 | 117 | 3 | SM00064 | |
| Domain | Spectrin_repeat | 7.77e-04 | 29 | 117 | 3 | IPR002017 | |
| Domain | - | 7.96e-04 | 391 | 117 | 9 | 2.30.29.30 | |
| Domain | STAT_TF_DNA-bd_sub | 8.00e-04 | 7 | 117 | 2 | IPR012345 | |
| Domain | STAT | 8.00e-04 | 7 | 117 | 2 | IPR001217 | |
| Domain | STAT_int | 8.00e-04 | 7 | 117 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 8.00e-04 | 7 | 117 | 2 | IPR013801 | |
| Domain | STAT_bind | 8.00e-04 | 7 | 117 | 2 | PF02864 | |
| Domain | STAT_int | 8.00e-04 | 7 | 117 | 2 | PF02865 | |
| Domain | - | 8.00e-04 | 7 | 117 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 8.00e-04 | 7 | 117 | 2 | PF01017 | |
| Domain | - | 8.00e-04 | 7 | 117 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 8.00e-04 | 7 | 117 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 8.00e-04 | 7 | 117 | 2 | IPR015988 | |
| Domain | - | 8.00e-04 | 7 | 117 | 2 | 2.60.40.630 | |
| Domain | P-loop_NTPase | DDX47 NLRP7 TDRD9 ZGRF1 RNF213 MAGI3 CHD1 BTAF1 CHD1L SLFN5 ABCA8 KIF20B MAGI2 DYNC1LI1 | 8.50e-04 | 848 | 117 | 14 | IPR027417 |
| Domain | RhoGEF | 8.75e-04 | 68 | 117 | 4 | SM00325 | |
| Domain | RhoGEF | 9.75e-04 | 70 | 117 | 4 | PF00621 | |
| Domain | DH_2 | 9.75e-04 | 70 | 117 | 4 | PS50010 | |
| Domain | - | 1.03e-03 | 71 | 117 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.03e-03 | 71 | 117 | 4 | IPR000219 | |
| Domain | SNF2_N | 1.04e-03 | 32 | 117 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.04e-03 | 32 | 117 | 3 | PF00176 | |
| Domain | SPEC | 1.04e-03 | 32 | 117 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.04e-03 | 32 | 117 | 3 | IPR018159 | |
| Domain | STAT_TF_alpha | 1.06e-03 | 8 | 117 | 2 | IPR013800 | |
| Domain | Chorein_N | 1.06e-03 | 8 | 117 | 2 | PF12624 | |
| Domain | VPS13_N | 1.06e-03 | 8 | 117 | 2 | IPR026854 | |
| Domain | Znf_FYVE-rel | 1.24e-03 | 34 | 117 | 3 | IPR017455 | |
| Domain | PH_dom-like | 1.45e-03 | 426 | 117 | 9 | IPR011993 | |
| Domain | LRR | 1.68e-03 | 201 | 117 | 6 | PS51450 | |
| Domain | MAC_perforin | 1.69e-03 | 10 | 117 | 2 | IPR001862 | |
| Domain | Znf_FYVE | 1.72e-03 | 38 | 117 | 3 | IPR000306 | |
| Domain | ZF_FYVE | 2.00e-03 | 40 | 117 | 3 | PS50178 | |
| Domain | MACPF | 2.06e-03 | 11 | 117 | 2 | PF01823 | |
| Domain | Rho_GTPase_activation_prot | 2.28e-03 | 88 | 117 | 4 | IPR008936 | |
| Domain | MACPF | 2.46e-03 | 12 | 117 | 2 | IPR020864 | |
| Domain | MACPF | 2.46e-03 | 12 | 117 | 2 | SM00457 | |
| Domain | TPR-contain_dom | 2.55e-03 | 150 | 117 | 5 | IPR013026 | |
| Domain | - | 2.55e-03 | 150 | 117 | 5 | 2.30.42.10 | |
| Domain | - | 2.67e-03 | 92 | 117 | 4 | 3.90.190.10 | |
| Domain | ANX | 2.90e-03 | 13 | 117 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 2.90e-03 | 13 | 117 | 2 | IPR018252 | |
| Domain | Annexin | 2.90e-03 | 13 | 117 | 2 | PF00191 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGEF19 NET1 RASGRF2 SPTBN1 DVL1 DVL3 ARHGAP11A PPP2R5A PTPN13 PPP2R5C PPP2R5D DST SRGAP3 SRGAP1 DYNC1LI1 PRKCD MCF2L ARHGAP11B | 1.38e-07 | 649 | 91 | 18 | MM15690 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGEF19 NET1 RASGRF2 SPTBN1 DVL1 DVL3 ARHGAP11A PPP2R5A PTPN13 PPP2R5C PPP2R5D DST SRGAP3 SRGAP1 DYNC1LI1 PRKCD MCF2L ARHGAP11B | 6.38e-07 | 720 | 91 | 18 | M41838 |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.49e-06 | 31 | 91 | 5 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.49e-06 | 31 | 91 | 5 | MM15154 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 5.85e-06 | 19 | 91 | 4 | M41732 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 2.95e-05 | 28 | 91 | 4 | M41724 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 3.02e-05 | 10 | 91 | 3 | M41731 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 3.63e-05 | 142 | 91 | 7 | MM15576 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 4.49e-05 | 100 | 91 | 6 | MM15826 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 4.93e-05 | 149 | 91 | 7 | M41805 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 1.12e-04 | 15 | 91 | 3 | M27407 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF19 NET1 RASGRF2 SPTBN1 ARHGAP11A PTPN13 DST SRGAP3 SRGAP1 MCF2L ARHGAP11B | 1.18e-04 | 439 | 91 | 11 | MM15595 |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 1.37e-04 | 16 | 91 | 3 | M47870 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.37e-04 | 16 | 91 | 3 | MM15710 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.37e-04 | 16 | 91 | 3 | M41733 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF19 NET1 RASGRF2 SPTBN1 ARHGAP11A PTPN13 DST SRGAP3 SRGAP1 MCF2L ARHGAP11B | 1.47e-04 | 450 | 91 | 11 | M27078 |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.66e-04 | 17 | 91 | 3 | MM15096 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 1.66e-04 | 17 | 91 | 3 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.66e-04 | 17 | 91 | 3 | M919 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 1.98e-04 | 18 | 91 | 3 | MM14759 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 2.34e-04 | 19 | 91 | 3 | M47525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 2.74e-04 | 20 | 91 | 3 | M47876 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 2.74e-04 | 20 | 91 | 3 | M90 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.87e-04 | 140 | 91 | 6 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.99e-04 | 141 | 91 | 6 | MM15266 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.18e-04 | 21 | 91 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.18e-04 | 21 | 91 | 3 | MM14996 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 3.47e-04 | 52 | 91 | 4 | MM14743 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.50e-04 | 94 | 91 | 5 | MM15598 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.67e-04 | 22 | 91 | 3 | M47919 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 4.07e-04 | 5 | 91 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 4.07e-04 | 5 | 91 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 4.07e-04 | 5 | 91 | 2 | M49006 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS | 4.07e-04 | 5 | 91 | 2 | M27447 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 4.95e-04 | 155 | 91 | 6 | M41808 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 5.64e-04 | 59 | 91 | 4 | M11215 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 6.08e-04 | 6 | 91 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 6.08e-04 | 6 | 91 | 2 | MM15621 | |
| Pathway | WP_WNT_SIGNALING | 6.40e-04 | 61 | 91 | 4 | MM15893 | |
| Pathway | WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN | 6.80e-04 | 27 | 91 | 3 | M39827 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 8.47e-04 | 7 | 91 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 8.47e-04 | 7 | 91 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 8.47e-04 | 7 | 91 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 8.47e-04 | 7 | 91 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 8.47e-04 | 7 | 91 | 2 | M27907 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.08e-03 | 70 | 91 | 4 | MM14824 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 1.13e-03 | 8 | 91 | 2 | M27100 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 1.13e-03 | 8 | 91 | 2 | M27349 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.23e-03 | 33 | 91 | 3 | MM1404 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.35e-03 | 34 | 91 | 3 | M27556 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.35e-03 | 34 | 91 | 3 | MM15985 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 1.35e-03 | 34 | 91 | 3 | M42555 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.35e-03 | 34 | 91 | 3 | M27405 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.36e-03 | 257 | 91 | 7 | MM14755 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.44e-03 | 9 | 91 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.44e-03 | 9 | 91 | 2 | MM1419 | |
| Pathway | REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL | 1.44e-03 | 9 | 91 | 2 | MM14792 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.44e-03 | 9 | 91 | 2 | M8066 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 1.46e-03 | 76 | 91 | 4 | M19832 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.47e-03 | 35 | 91 | 3 | MM15271 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.54e-03 | 77 | 91 | 4 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.77e-03 | 80 | 91 | 4 | M800 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.79e-03 | 10 | 91 | 2 | M27898 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.79e-03 | 10 | 91 | 2 | MM15618 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.85e-03 | 81 | 91 | 4 | M39490 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.95e-03 | 202 | 91 | 6 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.05e-03 | 204 | 91 | 6 | M4217 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.16e-03 | 40 | 91 | 3 | M39595 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 2.18e-03 | 11 | 91 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.18e-03 | 11 | 91 | 2 | MM15578 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.21e-03 | 85 | 91 | 4 | MM14746 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 2.49e-03 | 42 | 91 | 3 | MM15274 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.61e-03 | 12 | 91 | 2 | M27893 | |
| Pathway | REACTOME_KILLING_MECHANISMS | 2.61e-03 | 12 | 91 | 2 | M29844 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY | 2.66e-03 | 43 | 91 | 3 | M27560 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 2.93e-03 | 151 | 91 | 5 | M19428 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | PIK3AP1 SPTBN1 RNF213 NOX4 STAT5A STAT5B PPP2R5A PPP2R5C PPP2R5D | 3.02e-03 | 464 | 91 | 9 | M27547 |
| Pathway | PID_RHOA_REG_PATHWAY | 3.23e-03 | 46 | 91 | 3 | M68 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.56e-03 | 158 | 91 | 5 | MM14791 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 3.56e-03 | 97 | 91 | 4 | M9400 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 3.57e-03 | 14 | 91 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 3.57e-03 | 14 | 91 | 2 | M135 | |
| Pubmed | Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. | 6.53e-08 | 12 | 120 | 4 | 16541024 | |
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 8817329 | ||
| Pubmed | Human dishevelled genes constitute a DHR-containing multigene family. | 1.60e-07 | 4 | 120 | 3 | 9192851 | |
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 30679796 | ||
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 26308771 | ||
| Pubmed | 3.99e-07 | 5 | 120 | 3 | 8812429 | ||
| Pubmed | 3.99e-07 | 5 | 120 | 3 | 15095873 | ||
| Pubmed | 3.99e-07 | 5 | 120 | 3 | 26603207 | ||
| Pubmed | 3.99e-07 | 5 | 120 | 3 | 15677474 | ||
| Pubmed | ERC1 SPTBN1 DVL3 MAGI3 STAT5B RUFY2 WDR19 MAGI2 NPRL2 PTPN13 ACAD8 DST MORF4L1 MTMR3 ATXN10 PRKDC HERC2 MBD4 | 4.50e-07 | 1285 | 120 | 18 | 35914814 | |
| Pubmed | 1.39e-06 | 7 | 120 | 3 | 8703017 | ||
| Pubmed | Identification of a new family of protein phosphatase 2A regulatory subunits. | 1.39e-06 | 7 | 120 | 3 | 7592815 | |
| Pubmed | 1.39e-06 | 7 | 120 | 3 | 22031092 | ||
| Pubmed | 2.22e-06 | 8 | 120 | 3 | 30930146 | ||
| Pubmed | 3.31e-06 | 9 | 120 | 3 | 19417088 | ||
| Pubmed | 3.31e-06 | 9 | 120 | 3 | 30595372 | ||
| Pubmed | Direct binding between BubR1 and B56-PP2A phosphatase complexes regulate mitotic progression. | 3.31e-06 | 9 | 120 | 3 | 23345399 | |
| Pubmed | 3.31e-06 | 9 | 120 | 3 | 19797429 | ||
| Pubmed | 6.48e-06 | 11 | 120 | 3 | 9464256 | ||
| Pubmed | 8.61e-06 | 12 | 120 | 3 | 8703127 | ||
| Pubmed | 8.61e-06 | 12 | 120 | 3 | 15380617 | ||
| Pubmed | 1.12e-05 | 13 | 120 | 3 | 21072166 | ||
| Pubmed | 1.12e-05 | 13 | 120 | 3 | 23576434 | ||
| Pubmed | 1.17e-05 | 145 | 120 | 6 | 28846114 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23151802 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 26999798 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.18e-05 | 2 | 120 | 2 | 31443474 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12377952 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 38046902 | ||
| Pubmed | Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study. | 1.18e-05 | 2 | 120 | 2 | 12965206 | |
| Pubmed | Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness. | 1.18e-05 | 2 | 120 | 2 | 39262774 | |
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.18e-05 | 2 | 120 | 2 | 21127177 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16289657 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 25552366 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12616532 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.18e-05 | 2 | 120 | 2 | 21431790 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 28500076 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21826656 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.18e-05 | 2 | 120 | 2 | 27264955 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 9344861 | ||
| Pubmed | C5 and SRGAP3 Polymorphisms Are Linked to Paediatric Allergic Asthma in the Italian Population. | 1.18e-05 | 2 | 120 | 2 | 35205259 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22159083 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 20008792 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 33199496 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16502315 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12217382 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22271578 | ||
| Pubmed | Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism. | 1.18e-05 | 2 | 120 | 2 | 39181131 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 31599926 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10594041 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21036145 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10486277 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 36924504 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 1.18e-05 | 2 | 120 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 1.18e-05 | 2 | 120 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 1.18e-05 | 2 | 120 | 2 | 30377054 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 1.18e-05 | 2 | 120 | 2 | 32790723 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 18492722 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10066807 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10835485 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 39047119 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 35464049 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 1.18e-05 | 2 | 120 | 2 | 23773921 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 1.18e-05 | 2 | 120 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 1.18e-05 | 2 | 120 | 2 | 24878107 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12847485 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12835478 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 1.18e-05 | 2 | 120 | 2 | 24497979 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 1.18e-05 | 2 | 120 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 1.18e-05 | 2 | 120 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 1.18e-05 | 2 | 120 | 2 | 10486314 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 1.18e-05 | 2 | 120 | 2 | 24497923 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 1.18e-05 | 2 | 120 | 2 | 29460051 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 33537085 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 28606561 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8644734 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 1.18e-05 | 2 | 120 | 2 | 12393407 | |
| Pubmed | Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. | 1.18e-05 | 2 | 120 | 2 | 9774685 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12039059 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24040443 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21178171 | ||
| Pubmed | A single splice site mutation in human-specific ARHGAP11B causes basal progenitor amplification. | 1.18e-05 | 2 | 120 | 2 | 27957544 | |
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 1.18e-05 | 2 | 120 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 1.18e-05 | 2 | 120 | 2 | 16775227 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17447893 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 37057874 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 25692509 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16115927 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23275557 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 11867689 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 1.18e-05 | 2 | 120 | 2 | 15980098 | |
| Interaction | TULP3 interactions | SRP72 TMEM33 WDR19 RAB3GAP1 DST MTHFR MORF4L1 MTMR3 PRKAG1 WDR35 DYNC1LI1 | 5.59e-06 | 346 | 117 | 11 | int:TULP3 |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.65e-05 | 15 | 80 | 3 | 696 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 7.01e-05 | 50 | 80 | 4 | 721 | |
| GeneFamily | SH2 domain containing | 8.49e-05 | 101 | 80 | 5 | 741 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 1.15e-04 | 4 | 80 | 2 | 505 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.08e-04 | 66 | 80 | 4 | 722 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.43e-04 | 31 | 80 | 3 | 81 | |
| GeneFamily | PDZ domain containing | 5.69e-04 | 152 | 80 | 5 | 1220 | |
| GeneFamily | Annexins|Endogenous ligands | 1.46e-03 | 13 | 80 | 2 | 404 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.96e-03 | 15 | 80 | 2 | 903 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 4.61e-03 | 23 | 80 | 2 | 1288 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 5.01e-03 | 24 | 80 | 2 | 615 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.87e-03 | 26 | 80 | 2 | 904 | |
| GeneFamily | Phosphoinositide phosphatases | 8.80e-03 | 32 | 80 | 2 | 1079 | |
| Coexpression | GSE27786_LSK_VS_ERYTHROBLAST_UP | 3.80e-06 | 200 | 119 | 8 | M4757 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.30e-07 | 177 | 120 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.83e-07 | 191 | 120 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-06 | 151 | 120 | 6 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-06 | 167 | 120 | 6 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 8.31e-06 | 176 | 120 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-06 | 180 | 120 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 187 | 120 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.21e-05 | 188 | 120 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 189 | 120 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.36e-05 | 192 | 120 | 6 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.36e-05 | 192 | 120 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 192 | 120 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-05 | 195 | 120 | 6 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.49e-05 | 195 | 120 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-05 | 198 | 120 | 6 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.62e-05 | 198 | 120 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.67e-05 | 199 | 120 | 6 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.67e-05 | 199 | 120 | 6 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.72e-05 | 200 | 120 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.72e-05 | 200 | 120 | 6 | 9279415f5e76cb5b4e071c6582ac249b72dd694c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.72e-05 | 200 | 120 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Proliferating-Cycling|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.72e-05 | 200 | 120 | 6 | d582385b2dbb25eeba1b22c5d258a8f26a40ef8b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.02e-05 | 141 | 120 | 5 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.50e-05 | 156 | 120 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.77e-05 | 162 | 120 | 5 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.99e-05 | 163 | 120 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.96e-05 | 167 | 120 | 5 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.22e-05 | 168 | 120 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-05 | 169 | 120 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 9.48e-05 | 169 | 120 | 5 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 169 | 120 | 5 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.48e-05 | 169 | 120 | 5 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-05 | 170 | 120 | 5 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 1.00e-04 | 171 | 120 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.00e-04 | 171 | 120 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 171 | 120 | 5 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 173 | 120 | 5 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 173 | 120 | 5 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 175 | 120 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.15e-04 | 176 | 120 | 5 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-04 | 176 | 120 | 5 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | BAL-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 1.15e-04 | 176 | 120 | 5 | f9b0c3ced391e7ebe6b242d3f12ba14741f88d22 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 178 | 120 | 5 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class (2021.01.30) | 1.21e-04 | 178 | 120 | 5 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 179 | 120 | 5 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-04 | 180 | 120 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 180 | 120 | 5 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 181 | 120 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-04 | 182 | 120 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | droplet-Fat-Scat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 182 | 120 | 5 | fea094fe0e7796c084e60b5310c1559658633f7a | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.38e-04 | 183 | 120 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 1.38e-04 | 183 | 120 | 5 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 120 | 5 | d9be5853acdda7b1ac819cf50c7940d1d2362d15 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 185 | 120 | 5 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.45e-04 | 185 | 120 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 185 | 120 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 185 | 120 | 5 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 120 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 186 | 120 | 5 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.48e-04 | 186 | 120 | 5 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 186 | 120 | 5 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 120 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 120 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 120 | 5 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.52e-04 | 187 | 120 | 5 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 120 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 120 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 187 | 120 | 5 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 189 | 120 | 5 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-04 | 189 | 120 | 5 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 189 | 120 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-04 | 189 | 120 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-04 | 190 | 120 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-04 | 190 | 120 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 190 | 120 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.64e-04 | 190 | 120 | 5 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 190 | 120 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 190 | 120 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-04 | 190 | 120 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.68e-04 | 191 | 120 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | (1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.68e-04 | 191 | 120 | 5 | 66ddff9a99092cb384b9fb2a3ba95ddbebed67cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-04 | 191 | 120 | 5 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th17|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-04 | 191 | 120 | 5 | b3ed4797a7a9810cf3507e0d0f23f45c35bd8ba2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-04 | 191 | 120 | 5 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 193 | 120 | 5 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.76e-04 | 193 | 120 | 5 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 1.76e-04 | 193 | 120 | 5 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.76e-04 | 193 | 120 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.76e-04 | 193 | 120 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.76e-04 | 193 | 120 | 5 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.76e-04 | 193 | 120 | 5 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 193 | 120 | 5 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 193 | 120 | 5 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.81e-04 | 194 | 120 | 5 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 194 | 120 | 5 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.81e-04 | 194 | 120 | 5 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-04 | 194 | 120 | 5 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.81e-04 | 194 | 120 | 5 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 4.58e-05 | 3 | 116 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Robinow Syndrome | 9.15e-05 | 4 | 116 | 2 | C0265205 | |
| Disease | Cranioectodermal dysplasia | 9.15e-05 | 4 | 116 | 2 | cv:C4551571 | |
| Disease | Robinow Syndrome, Autosomal Dominant | 9.15e-05 | 4 | 116 | 2 | C4551476 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 1.52e-04 | 5 | 116 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 1.52e-04 | 5 | 116 | 2 | C0432235 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.81e-04 | 28 | 116 | 3 | DOID:3717 (is_marker_for) | |
| Disease | fatty liver disease (is_implicated_in) | 3.18e-04 | 7 | 116 | 2 | DOID:9452 (is_implicated_in) | |
| Disease | Moyamoya disease | 5.26e-04 | 40 | 116 | 3 | MONDO_0016820 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 5.42e-04 | 9 | 116 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Combined immunodeficiency | 5.66e-04 | 41 | 116 | 3 | C0494261 | |
| Disease | Cakut | 1.16e-03 | 13 | 116 | 2 | C1968949 | |
| Disease | Nephronophthisis | 1.16e-03 | 13 | 116 | 2 | C0687120 | |
| Disease | diastolic blood pressure, body mass index | 1.77e-03 | 16 | 116 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | acute lymphoblastic leukemia | 2.26e-03 | 66 | 116 | 3 | EFO_0000220 | |
| Disease | hearing loss | 2.36e-03 | 67 | 116 | 3 | EFO_0004238 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 2.51e-03 | 19 | 116 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.62e-03 | 145 | 116 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NET1 RASGRF2 DVL3 HMMR ARHGAP11A MCOLN1 STAT5A MTHFR SRGAP3 MTMR3 HERC2 | 3.42e-03 | 1074 | 116 | 11 | C0006142 |
| Disease | nicotine dependence | 3.63e-03 | 78 | 116 | 3 | EFO_0003768 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HLENTKGFNLRALKY | 156 | Q9H0S4 | |
| NLIKKYGTHFLLSAT | 126 | Q76B58 | |
| GNTLYILTHKRILKF | 161 | P54619 | |
| IRNFASGHYKKALLA | 301 | Q9UJ72 | |
| SLLTSAKKQGDHYIL | 171 | Q9UKU7 | |
| LTRVQFKLALHYFKN | 546 | Q8NHY0 | |
| SQARLHYLSGFIKKT | 1406 | Q8N7X0 | |
| KSHLIRLIGNLCYKN | 371 | Q9UBB4 | |
| GLHKVNTLALKYGLR | 946 | Q6TFL3 | |
| LEKRVFYKLISGLHA | 241 | Q86YB8 | |
| ALLKNYGLLHCFRKD | 186 | Q14406 | |
| DFLKTILHRIYGKFL | 256 | Q14738 | |
| FLKTTLHRIYGKFLG | 181 | Q13362 | |
| LDIRAHFKRLYGKSL | 281 | P09525 | |
| QIRLSKEHLLKNGLY | 261 | Q8NBA8 | |
| KYASNLLKAGFIRHT | 466 | Q92997 | |
| HFAAKYGLKNLTALL | 341 | Q6ZUJ8 | |
| LYKTLIDFKSNHRLL | 626 | O14646 | |
| FLTTKKLRRLYLSHN | 146 | Q9BXN1 | |
| QYTHLSGLLDIFKSK | 201 | Q15042 | |
| LDQNRSKLKLYIGHL | 1016 | Q8IUD2 | |
| LSKLHANGKILFYNV | 456 | Q99650 | |
| LLQHLRAFYGIKVKG | 11 | Q3KRB8 | |
| YLTSLKNLHLSGNRI | 81 | Q6ZNQ3 | |
| SSYKNLTLKFHKLVN | 216 | Q9GZU1 | |
| KSLALLLNYLHDFLK | 321 | Q9UBU8 | |
| GELRSKSGHKLYIFL | 391 | Q7Z628 | |
| KSGHKLYIFLFQDIL | 396 | Q7Z628 | |
| AKLKLSSKAVYLHLF | 611 | Q8IW93 | |
| FLLALFIIYRHKQKG | 871 | Q96KG7 | |
| GIKILYHKSLSLFIF | 486 | Q9H306 | |
| GYHSLRQLVKLSKLE | 261 | P42898 | |
| KDLRHYLNLRFQKGS | 106 | Q86UL8 | |
| KDLRHYLSLQFQKGS | 111 | Q5TCQ9 | |
| YLSLQFQKGSIDHKL | 116 | Q5TCQ9 | |
| RHLKYSLFKKSLLGS | 166 | Q8NHV4 | |
| ILITGAHKAFALYKA | 201 | P46926 | |
| LQFLHSKGIIYRDLK | 461 | Q05655 | |
| KHYGTIRTLLLNCLK | 476 | Q3B7T1 | |
| LKLYILKAGRALLSH | 2321 | O95714 | |
| KLHRLESQYAKLLNT | 676 | Q03001 | |
| FLLLYFNDTHKSIRK | 231 | O95972 | |
| LYHKGLLKFSLDAVS | 126 | Q9Y6G9 | |
| LDTLKQFLQYHGKIL | 216 | Q5JST6 | |
| LHYRAKLISDLLGAK | 26 | P16499 | |
| YLIHLRFQSSKSGKI | 1021 | Q32MH5 | |
| NSHKLLALYKSLARS | 6 | Q969I3 | |
| AYRLLKLGIKHQSVA | 326 | Q96Q89 | |
| YLHKAVFRGLLTEKA | 1716 | Q96RT7 | |
| ALIAISNYRLHIKFK | 51 | Q9NYA4 | |
| KIIGEKYHALNSRLF | 506 | Q9NPH5 | |
| IRDSYAKLLGHQNLK | 621 | O75330 | |
| DLRHFLYKSKSSGLF | 541 | Q86VX9 | |
| NKKYLHLDLLTGNLL | 71 | Q9Y5E9 | |
| LTHLYLSGNKIKDLS | 86 | O43423 | |
| RSNLDKLYHGLELAK | 406 | O75419 | |
| LGLFYQLLHKVDKAS | 36 | A1L0T0 | |
| KLKATGHVFQALQYL | 1561 | O14981 | |
| YLILSKGKIIHFGTR | 501 | P01031 | |
| SGKLHLLDKLLAFLY | 346 | Q86WJ1 | |
| YKKLLTLFRAGHDQV | 86 | Q9BQA9 | |
| LHLLYGKRDFLLSDK | 101 | Q9Y653 | |
| GLLFLYLKAKSHRHG | 1126 | Q9UHN6 | |
| LKFRSKSSLANYLHK | 116 | O95243 | |
| ILITGAHKAFALYKA | 201 | Q8TDQ7 | |
| QRKLDHKLSLDSYLL | 751 | O15068 | |
| THLLKKFDLGSYDIR | 881 | Q6P179 | |
| KQLHLKLATGRSFYL | 136 | Q8NEG0 | |
| EARKYASSLLKHGFL | 466 | O14640 | |
| EARKYASSLLKHGFL | 441 | P54792 | |
| TLLLHEKSLKFYGSI | 551 | A6NIM6 | |
| EYLFNKLTLGRSQKH | 131 | P0C7X4 | |
| AIIALSNYRLHIKFK | 51 | Q13615 | |
| FSYVKHLVKLVLGNL | 166 | Q12923 | |
| THYLKKLDFPALRNS | 1621 | A6NES4 | |
| FASIYKILHLLGKDS | 121 | Q92521 | |
| LLQHLRAFYGIKVKG | 11 | Q6P4F7 | |
| RTYKQRLLFAKLFGH | 576 | Q8N3S3 | |
| ELSFKKGASLLLYHR | 761 | Q7Z6B7 | |
| HGLKVRKSFLSYNKT | 56 | Q8WXA3 | |
| TRLQKLYLNGNHLTK | 411 | Q9H5Y7 | |
| KKRHFFQNLGSILTY | 151 | Q8IVB4 | |
| LLNGIIKDHFKTLSY | 106 | A0A494BZU4 | |
| GKNTFLYQLHKLVVL | 1366 | Q8NDG6 | |
| KKERLALYLLHTQGL | 1656 | A0AVI2 | |
| LALFLLHRYGDFKKQ | 16 | Q68DH5 | |
| HALYLAFLARKEGTK | 11 | O14827 | |
| LLIFLGKKIASLHNY | 371 | Q96RN1 | |
| LALTGKINLFVHKYG | 231 | Q6ZNX1 | |
| FLLKIKLGHYATQLQ | 81 | P51692 | |
| FFYVLKANQSLKHLR | 781 | Q8WX94 | |
| LLCGQYSRALKHFLK | 1031 | Q8NEZ3 | |
| IEHKKYSRNALLFNL | 71 | Q8WTW4 | |
| HLSLIREAANFKLKY | 446 | O76094 | |
| LKSKHGDNYLVLNLS | 41 | Q68CZ2 | |
| LSKALSYALRHGALK | 31 | Q86TN4 | |
| IELGKSLLARKHYAS | 1971 | Q01082 | |
| FLLKIKLGHYATQLQ | 81 | P42229 | |
| SIQHLKSKFGKDYLL | 1501 | O94911 | |
| ENLIKKYGTHFLLSA | 136 | Q9C0B6 | |
| FLKTVLHRIYGKFLG | 206 | Q15172 | |
| GKAFNYSSLLRKHQI | 221 | Q8N782 | |
| RSVILKLLLKYSFHD | 4131 | Q63HN8 | |
| GKAFNYSSLLRKHQI | 221 | Q86XN6 | |
| AQLGKARLHLKLLDY | 2146 | Q96RL7 | |
| RELSFKKGASLLLYH | 761 | O43295 | |
| VLLILKRKTYNSHLA | 286 | Q96AG3 | |
| LTKLYLSHNRITFLK | 176 | Q9HBX9 | |
| AFLLYHRGFQSQVKK | 276 | O43159 | |
| LKYILLGKIFSSCFH | 326 | Q9P1P5 | |
| GKAFNYSSLLRKHQI | 221 | Q6ZN06 | |
| HSKNGKFLYFLRSRV | 481 | O14512 | |
| TKSLFKRLYSLALHP | 1056 | P78527 | |
| SNSLFYPLGKKHLIS | 761 | Q86YA3 | |
| LSGSQKIHLRKKSYL | 341 | Q96LW1 | |
| GKAFFLSSYLIRHQK | 381 | O75123 | |
| YLHPSFGKLNSLKSI | 161 | O60602 | |
| LLARYASHLLEKNKT | 916 | Q9P2L0 | |
| LASRAKRHLYILKAS | 876 | Q08AF3 | |
| LLFSLLHAATYTKKV | 116 | P57088 | |
| NYRLGLSKKSSLFSH | 216 | Q14929 | |
| LLLSKKLIYFQLHRA | 361 | Q13263 | |
| PRYLLDNKSSHKLAF | 3401 | Q5THJ4 | |
| VKKYHIDGARFLNLT | 36 | Q13094 | |
| LKNLKLLYLHDNGFA | 96 | A6PVS8 |